Pfizer Settles Foreign Bribery Charges, Wins Deferred Prosecution For Helping Government
This article was originally published in PharmAsia News
Executive Summary
Pfizer reaches separate settlements with U.S. DoJ and SEC to resolve charges its subsidiaries bribed Chinese, Russian and other foreign government officials; a subsidiary enters a deferred prosecution agreement with DoJ.